A critique of hypertension treatment trials and of their evaluation
Related Experiment Video
Updated: Jul 23, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
1Elmbank, Bowling, Glasgow, UK.
Insights
Antihypertensive drug therapy offers significant cardiovascular benefits. However, flawed studies and diagnostic criteria have led to exaggerated claims, diminishing the perceived value of this essential treatment.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Trials
Background:
- Antihypertensive drug therapy has advanced significantly over four decades.
- These advancements have demonstrably reduced cardiovascular complications.
Purpose of the Study:
- To critically evaluate the reported benefits of antihypertensive drug therapy.
- To address the impact of flawed meta-analyses and diagnostic criteria on treatment perception.
Main Methods:
- Review of meta-analyses incorporating antihypertensive drug trials.
- Analysis of diagnostic criteria used for adverse coronary events in hypertension studies.
Main Results:
- Inclusion of defective trials in meta-analyses resulted in exaggerated claims.
- Inappropriate diagnostic criteria for adverse coronary events skewed results.
- The perceived advantages of antihypertensive treatment have been overstated.
Conclusions:
- Despite proven benefits, the value of prophylactic drug therapy for hypertension is currently underestimated.
- Methodological issues in research have inadvertently devalued effective treatments.
- Accurate assessment of antihypertensive therapy benefits requires rigorous trial evaluation and standardized diagnostic criteria.
Abstract:
Progressive improvements in antihypertensive drug therapy over the past four decades have provided clear benefits in limiting cardiovascular complications. Unfortunately, and largely inexplicably, the inclusion in meta-analyses of defective trials plus the employment of inappropriate diagnostic criteria for adverse coronary events have led to spurious, exaggerated claims for the advantages of such treatment. The consequence has been a devaluation of the very real worth of prophylactic drug therapy for hypertension.
Related Concept Videos
Errors occurring during blood pressure monitoring
Several factors...
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management

